Skip to main content
. 2017 Dec 27;9(7):7359–7371. doi: 10.18632/oncotarget.23670

Figure 4. Overall survival of patients stratified according to gene expression.

Figure 4

Kaplan-Meier analyses showed that patients with high levels of PSCA, SPARC, THBS2 and THY1 genes had a significantly poor overall survival while high levels of CXCL9, HMGCS2 and SULT1B1 genes has a protective effect (p < 0.05).